Cart
sales@molnova.com
Ac4ManNAz
CAS No. 361154-30-5
Ac4ManNAz ( —— )
Catalog No. M21882 CAS No. 361154-30-5
Ac4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 160 | In Stock |
|
| 50MG | 241 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAc4ManNAz
-
NoteResearch use only, not for human use.
-
Brief DescriptionAc4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionAc4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number361154-30-5
-
Formula Weight430.37
-
Molecular FormulaC16H22N4O10
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (232.36 mM; Need ultrasonic)
-
SMILESO=C(N[C@@H]1C(OC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)CN=[N+]=[N-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
Fmoc-NH-PEG8-NHS est...
Fmoc-NH-PEG8-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
BRD4 degrader AT1
BRD4 degrader AT1 is a highly selective BED4 degrader (PROTAC), exhibits highly selective depletion of BRD4 in cells with negligible activity against BRD2 and BRD3.
-
Alkynyl Stearic Acid
Alkynyl Stearic Acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
